&w=3840&q=100)
DCM Shriram stock falls 2% after Q1 results; check key numbers here
At 10:25 AM, DCM Shriram stock was trading at ₹1,372.5, down 1.16 per cent from its previous day's close of ₹1,388.6 on the NSE. In comparison, the NSE Nifty50 index was up 29.85 points or 0.12 per cent at 25,115.4 levels. The company's total market capitalisation stood at ₹21,240.9 crore. The stock has fallen over 5.8 per cent from its 52-week high of ₹1,473.9 touched on July 3, 2025.
DCM Shriram Q1FY26 results
In the quarter ended June 30, 2025, DCM Shriram reported consolidated profit after tax (PAT) of ₹113.8 crore, up 13 per cent from ₹100.3 crore in the year-ago period. The company's revenue from operations stood at ₹3,455.2 crore, up 12.4 per cent compared to ₹3,073 crore in Q1FY25. Its profit before depreciation, interest and tax (PBDIT) also rose 19 per cent to ₹325.7 crore in the reported quarter compared to ₹273.7 crore in the year-ago quarter.
The company's revenue from the Chemicals and Vinyl segment increased 32 per cent year-on-year (Y-o-Y) to ₹1,114 crore compared to ₹842 crore in the June 2025 quarter. Revenue from the fertiliser business also grew 19 per cent Y-o-Y to ₹390 crore. However, the Sugar and Ethanol unit witnessed a decline of 14 per cent to ₹824 crore.
According to the exchange filing, DCM Shriram's net debt stood at ₹1,481 crore at the end of the June 2025 quarter, up 1.5 per cent from ₹1,459 crore in the corresponding quarter of the previous fiscal. Check List of Q1 results today
About DCM Shriram
Established in 1989, DCM Shriram is a diversified company with business in agri, chemicals, plastics, cement, textiles and energy services. The company's business portfolio comprises Chloro-Vinyl, Sugar, Shriram Farm Solutions, Bioseed, Fertilisers, Fenesta Building Systems and others. It operates manufacturing facilities in Kota in Rajasthan, Bharuch in Gujarat, and Ajbapur, Rupapur, Hariawan and Loni in Uttar Pradesh. The hybrid seed operations are based in Bhiwadi, Mumbai, Hyderabad and Chennai. The window fabrication units are located in Bhiwadi, Bangalore, Mumbai, Hyderabad and Chennai.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
4 hours ago
- Hans India
Honoured to witness signing of free trade pact between India and UK: Ashish Kumar Chauhan
London: Ashish Kumar Chauhan, MD and CEO of National Stock Exchange (NSE), said on Saturday that it was an honour to witness the signing of Free Trade agreement between India and the UK, in the presence of Prime Minister Narendra Modi and his counterpart Keir Starmer. 'Honoured and privileged to be a witness to the signing of Free Trade agreement between India and UK on July 24,2025 with Hon'ble PM India and Hon'ble PM Uk at the country residence of UK PM Chequers outside London, UK,' Chauhan said in a post on X social media platform. The landmark India-UK Free Trade Agreement (FTA) is an indication of several such trade pacts in the near future under the leadership of PM Modi, he had said earlier on Friday. Speaking to IANS here, Chauhan said that the talks on the India-UK FTA were ongoing for three-four years. 'When talks first began 4–5 years ago, the UK was under a Conservative government. Since then, there have been regime changes but the way both the Conservative and the Labour parties supported finalising the FTA is commendable,' he emphasised. According to Chauhan, the India-UK FTA will pave the way for several such trade pacts with other nations, like the US, the EU and Japan etc, in the near future. India and the EU are aiming to reach an agreement on a free trade deal by the end of 2025. The coming months will be crucial for India's global trade relations, as the government intensifies negotiations with major partners such as the EU and the ASEAN bloc. Meanwhile, talks with the US are also gaining pace. 'The world has seen the tremendous progress India has achieved in the last 11 years under PM Modi, and the FTA will bring a better future for several industries,' said the NSE CEO.
Mint
9 hours ago
- Mint
Upcoming IPO: Ashish Kacholia-owned Sahajanand Medical Technologies files DRHP for public issue launch
Upcoming IPO: Medical devices company Sahajanand Medical Technologies has filed its draft red herring prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (Sebi), on Friday, July 25, 2025. Founded by Dhirajlal Kotadia in 2001, Sahajanand Medical Technologies (SMT) Limited specialises in advanced medical devices in vascular and structural heart intervention. Ashish Kacholia, Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and Plutus Wealth Management LLP are the major shareholders in the company. According to the DRHP filing, the company is offering a book-built initial public offering (IPO) with an entirely offer for sale (OFS) component. The company proposed to make an offer-for-sale of up to 2,76,44,231 equity shares to shareholders with a face value of Re 1 apiece. The offer also provides a discounted subscription reservation for eligible employees within the employee reservation section. The public issue consists of stakes of up to 27,00,000 equity shares each of Shree Hari Trust and Dhirajkumar Savjibhai Vasoya, around 1,29,58,126 equity shares by Samara Capital Markets Holding Limited, up to 26,15,750 equity shares by Kotak Pre-IPO Opportunities Fund, and up to 66,70,355 equity shares by NHPEA Sparkle Holding B.V. The offer is conducted through a book-building process, with up to 50% allocated to qualified institutional buyers and at least 15% and 35% assigned to non-institutional and retail individual bidders, respectively, according to the draft papers. The equity shares are proposed to be listed on the NSE and BSE. The book-running lead managers for the public issue are Motilal Oswal Investment Advisors, Avendus Capital Private, HSBC Securities and Capital Markets (India), and Nuvama Wealth Management. MUFG Intime India is the registrar. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
Time of India
9 hours ago
- Time of India
Brigade Hotel Ventures' IPO subscribed 1.19 times on day 2 of offer
NEW DELHI: The initial share sale of Brigade Hotel Ventures Ltd received 1.19 times subscription on the second day of bidding on Friday. The company's initial public offering (IPO) got bids for 6,09,28,972 shares against 5,11,93,987 shares on offer, according to data available with the NSE. Retail Individual Investors (RIIs) part got subscribed 4.65 times while the portion for non-institutional investors received 98 per cent subscription. The Qualified Institutional Buyers (QIBs) category fetched 8 per cent subscription. Brigade Hotel Ventures Ltd on Wednesday raised Rs 325 crore from anchor investors. The IPO will conclude on July 28. The price band has been fixed at Rs 85 to Rs 90 per share. At the upper end of the price band, the company is valued at over Rs 3,400 crore. Brigade Hotel Ventures' IPO is entirely a fresh issue of equity shares worth Rs 759.6 crore with no offer-for-sale (OFS) component. Proceeds from the issue to the tune of Rs 468.14 crore will be used for the payment of debt, Rs 107.52 crore will be utilised for the purchase of an undivided share of land from the promoter, BEL, and the remaining funds will support acquisitions, other strategic initiatives, and general corporate purposes. Brigade Hotel Ventures Ltd is a subsidiary of Bengaluru-based real estate company Brigade Enterprises Ltd (BEL). BEL entered into the hospitality business in 2004 with the development of its first hotel, Grand Mercure Bangalore, which commenced operations in 2009. The company has a portfolio of nine operating hotels across Bengaluru (Karnataka), Chennai (Tamil Nadu), Kochi (Kerala), Mysuru (Karnataka) and the GIFT City (Gujarat) with 1,604 keys. The hotels are operated by global marquee hospitality companies such as Marriott, Accor and InterContinental Hotels Group. JM Financial and ICICI Securities are the book-running lead managers to the issue.
